$NEOT Evofem Biosciences, Inc. Insider Trading
Get free email notifications about insider trading in Evofem Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evofem Biosciences, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Evofem Biosciences, Inc. for free.
CIK Number: 0001618835
IRS Number: 208527075
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NEOT
Company Address: 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO 92130
Phone number: (858) 550-1900
Former name: Neothetics, Inc., date of change: 2014-09-05
Market Capitalization: $26.27M
Prev close: $1.70
Average Daily Volume: 138,885
Days Low: $1.67
Year Low: $0.53
Year High: $1.97
Evofem Biosciences, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Buy | P | 1.03 | 24,500 | 25,235 | 440,388 | 415.9 K to 440.4 K (+5.89 %) |
May 13 2021 | NEOT | Evofem Biosciences ... | Greer Gillian | Director | Option Exercise | A | 1.25 | 90,000 | 112,500 | 90,000 | |
May 13 2021 | NEOT | Evofem Biosciences ... | Rutherford Colin | Director | Option Exercise | A | 1.25 | 90,000 | 112,500 | 90,000 | |
May 13 2021 | NEOT | Evofem Biosciences ... | Hall William Walmsley | Director | Option Exercise | A | 1.25 | 90,000 | 112,500 | 90,000 | |
Mar 09 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Buy | P | 2.28 | 45,249 | 103,168 | 906,137 | 860.9 K to 906.1 K (+5.26 %) |
Feb 03 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Option Exercise | A | 3.25 | 700,000 | 2,275,000 | 700,000 | |
Feb 03 2021 | NEOT | Evofem Biosciences ... | PELLETIER SAUNDRA L | Chief Executive Off ... | Grant | A | 0.00 | 500,000 | 0 | 860,888 | 360.9 K to 860.9 K (+138.55 %) |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Barrans Russell | Chief Commercial Of ... | Grant | A | 0.00 | 200,000 | 0 | 481,852 | 281.9 K to 481.9 K (+70.96 %) |
Feb 03 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
Feb 03 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 200,000 | 0 | 458,168 | 258.2 K to 458.2 K (+77.47 %) |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Fitzpatrick Alexander A | General Counsel and ... | Grant | A | 0.00 | 200,000 | 0 | 343,542 | 143.5 K to 343.5 K (+139.33 %) |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
Feb 03 2021 | NEOT | Evofem Biosciences ... | Culwell Kelly | Chief Medical Offic ... | Grant | A | 0.00 | 200,000 | 0 | 315,451 | 115.5 K to 315.5 K (+173.23 %) |